Preliminary application of SPECT/CT imagingby(99)Tc(m)-tricine-EDDA-Hynic-c-Met for non-small-cell lung cancer

Conclusions: Using c-Met as the target, SPECT/CT imaging through radioactive isotopes labeled 99Tcm-tricine-EDDA-Hynic-c-Met molecular probe can be used to screen indicators of NSCLC treated by c-Met inhibitor-mediated targeted drug therapy, which provides idea for further research.
Source: Journal of Nuclear Medicine - Category: Nuclear Medicine Authors: Tags: Preclinical Probes for Oncology Posters Source Type: research